Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages

Pancreatic ductal adenocarcinoma (PDAC) tumor growth is enhanced by tumor-associated macrophages (TAMs), yet the mechanisms by which tumor cells and TAMs communicate are not fully understood. Here we show that exosomes secreted by PDAC cell lines differed in their surface proteins, lipid composition, and efficiency of fusing with THP-1-derived macrophages in vitro. Exosomes from AsPC-1, an ascites-derived human PDAC cell line, were enriched in ICAM-1, which mediated their docking to macrophages through interactions with surface-exposed CD11c on macrophages. AsPC-1 exosomes also contained much higher levels of arachidonic acid (AA), and they fused at a higher rate with THP-1-derived macrophages than did exosomes from other PDAC cell lines or from an immortalized normal pancreatic ductal epithelial cell line (HPDE) H6c7. Phospholipase A2 enzymatic cleavage of arachidonic acid from AsPC-1 exosomes reduced fusion efficiency. PGE2 secretion was elevated in macrophages treated with AsPC-1 exosomes but not in macrophages treated with exosomes from other cell lines, suggesting a functional role for the AsPC-1 exosome-delivered arachidonic acid in macrophages. Non-polarized (M0) macrophages treated with AsPC-1 exosomes had increased levels of surface markers indicative of polarization to an immunosuppressive M2-like phenotype (CD14hi CD163hi CD206hi). Furthermore, macrophages treated with AsPC-1 exosomes had significantly increased secretion of pro-tumoral, bioactive molecules including VEGF, MCP-1, IL-6, IL-1β, MMP-9, and TNFα. Together, these results demonstrate that compared to exosomes from other primary tumor-derived PDAC cell lines, AsPC-1 exosomes alter THP-1-derived macrophage phenotype and function. AsPC-1 exosomes mediate communication between tumor cells and TAMs that contributes to tumor progression.

[1]  J. Pollard,et al.  Diverse Functions of Macrophages in Different Tumor Microenvironments. , 2018, Cancer research.

[2]  W. Xiao,et al.  A RIPK3-PGE2 Circuit Mediates Myeloid-Derived Suppressor Cell-Potentiated Colorectal Carcinogenesis. , 2018, Cancer research.

[3]  Honglin Li,et al.  Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2 , 2018, BMC Cancer.

[4]  R. Hoffman,et al.  Differential Organ-targeting and Cellular Characteristics of Metastatic Human Pancreatic Cancer Cell Lines in Mouse Models. , 2018, Anticancer research.

[5]  K. Lim,et al.  Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer. , 2018, Cancer research.

[6]  S. Caja,et al.  Exosome-Based Cell-Cell Communication in the Tumor Microenvironment , 2018, Front. Cell Dev. Biol..

[7]  N. Rothman,et al.  Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk , 2017, International journal of cancer.

[8]  C. Rao,et al.  Loss of natural killer T cells promotes pancreatic cancer in LSL‐KrasG12D/+ mice , 2017, Immunology.

[9]  C. Bonifer,et al.  Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the ApcMin/+ mouse model of intestinal tumorigenesis , 2017, Scientific Reports.

[10]  R. Brekken,et al.  Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies , 2017, British Journal of Cancer.

[11]  Xiaoqing Pan,et al.  IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma , 2017, Molecular Cancer Therapeutics.

[12]  T. Whiteside Exosomes carrying immunoinhibitory proteins and their role in cancer , 2017, Clinical and experimental immunology.

[13]  R. Berger,et al.  Pancreatic cancer ascites xenograft–an expeditious model mirroring advanced therapeutic resistant disease , 2017, Oncotarget.

[14]  S. Dow,et al.  Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α , 2017, Cancer Immunology, Immunotherapy.

[15]  G. Pidgeon,et al.  Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway , 2017, International journal of molecular sciences.

[16]  D. Curiel,et al.  COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells , 2017, Proceedings of the National Academy of Sciences.

[17]  P. Nandi,et al.  PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells , 2017, BMC Cancer.

[18]  D. Mukhopadhyay,et al.  Immunosuppressive CD14+HLA-DRlo/neg monocytes are elevated in pancreatic cancer and “primed” by tumor-derived exosomes , 2017, Oncoimmunology.

[19]  Joshua M. Weiss,et al.  Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. , 2016, Cancer cell.

[20]  M. Lowery,et al.  Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications. , 2016, Clinical colorectal cancer.

[21]  Y. Chun,et al.  Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials , 2016, Oncotarget.

[22]  M. Amiji,et al.  Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems , 2016, Scientific Reports.

[23]  M. Setou,et al.  Accumulation of arachidonic acid-containing phosphatidylinositol at the outer edge of colorectal cancer , 2016, Scientific Reports.

[24]  A. Schulze,et al.  Systematic Analysis Reveals that Cancer Mutations Converge on Deregulated Metabolism of Arachidonate and Xenobiotics. , 2016, Cell reports.

[25]  Hai Hu,et al.  Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma , 2016, Oncotarget.

[26]  C. Théry,et al.  Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes , 2016, Proceedings of the National Academy of Sciences.

[27]  Hai Hu,et al.  The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer , 2016, Tumor Biology.

[28]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[29]  T. Arumugam,et al.  Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[30]  M. Raes,et al.  M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide , 2015, BMC Cancer.

[31]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[32]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[33]  J. Redzic,et al.  Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. , 2014, Biochimica et biophysica acta.

[34]  D. Bentrem,et al.  TOPIC HIGHLIGHT , 2014 .

[35]  R. Andersson,et al.  Tumour‐educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion , 2014, Immunology and cell biology.

[36]  Clotilde Théry,et al.  Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles , 2013, Journal of Cell Science.

[37]  R. DuBois,et al.  An Inflammatory Mediator, Prostaglandin E2, in Colorectal Cancer , 2013, Cancer journal.

[38]  R. Hwang,et al.  Prostaglandin E2 Regulates Pancreatic Stellate Cell Activity Via the EP4 Receptor , 2013, Pancreas.

[39]  M. Zöller,et al.  Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. , 2012, The international journal of biochemistry & cell biology.

[40]  A. Durczyński,et al.  Prostaglandin E2 (PGE2) in Portal Blood in Patients with Pancreatic Tumor—A Single Institution Series , 2012, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[41]  Y. Daaka,et al.  PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway. , 2011, Blood.

[42]  L. Daeffler,et al.  Pancreatic Cancer Cell Lines Can Induce Prostaglandin E2 Production from Human Blood Mononuclear Cells , 2011, Journal of oncology.

[43]  Chengliang Zhang,et al.  The TIP30 Protein Complex, Arachidonic Acid and Coenzyme A Are Required for Vesicle Membrane Fusion , 2011, PloS one.

[44]  M. Record,et al.  Exosomes as intercellular signalosomes and pharmacological effectors. , 2011, Biochemical pharmacology.

[45]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[46]  Bernard Monsarrat,et al.  Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins[S] , 2010, Journal of Lipid Research.

[47]  B. Chauffert,et al.  Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. , 2010, The Journal of clinical investigation.

[48]  A. Molinari,et al.  Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* , 2009, The Journal of Biological Chemistry.

[49]  A. Poliakov,et al.  Induction of myeloid‐derived suppressor cells by tumor exosomes , 2009, International journal of cancer.

[50]  M. Ahmadi,et al.  Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. , 2008, Cancer research.

[51]  H. Reber,et al.  Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. , 2008, Surgery.

[52]  H. McMahon,et al.  Mechanisms of membrane fusion: disparate players and common principles , 2008, Nature Reviews Molecular Cell Biology.

[53]  A. Shevchenko,et al.  Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.

[54]  H. Suemizu,et al.  Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. , 2007, International journal of oncology.

[55]  Li Zhu,et al.  Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells1 , 2005, The Journal of Immunology.

[56]  C. Théry,et al.  ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. , 2005, Blood.

[57]  Peng Sun,et al.  Fusion of Lamellar Body with Plasma Membrane Is Driven by the Dual Action of Annexin II Tetramer and Arachidonic Acid* , 2003, Journal of Biological Chemistry.

[58]  M. Tsao,et al.  Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. , 1998, The American journal of pathology.

[59]  A. Eklund,et al.  Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. , 1994, Cellular immunology.

[60]  E. Brown,et al.  Inhibition of endosome fusion by phospholipase A2 (PLA2) inhibitors points to a role for PLA2 in endocytosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[61]  N. Bhattacharya,et al.  An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer. , 2017, Cancer research.

[62]  B. Necela,et al.  Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. , 2015, Cancer discovery.

[63]  B. Chauffert,et al.  Membrane-associated Hsp 72 from tumor-derived exosomes mediates STAT 3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells , 2010 .